• Temozolomide Workflows for Glioma DNA-Damage Studies

  2026-08-26

  Temozolomide provides a reproducible DNA-damage challenge for glioma, DNA repair, and chemotherapy resistance experiments. Its strongest differentiation is the ability to pair a defined alkylation stimulus with ATRX-stratified RTK or PDGFR inhibitor assays.

• ANP Beyond Pressure: A Translational Research Playbook

  2026-08-26

  A mechanistic and strategic guide to using Atrial Natriuretic Peptide in cardiovascular, renal, metabolic, and carefully bounded neuroimmune research workflows.

• DiscoveryProbe Stem Cell Compound Library Plus

  2026-08-25

  DiscoveryProbe™ Stem Cell Compound Library Plus turns broad stem-cell pathway coverage into a practical workflow for phenotypic screening, differentiation studies, and mechanism-guided validation. Its strongest use case is pairing high-content imaging with orthogonal assays so pathway modulation, cell-state change, and general toxicity are not confused.

• Cy7 NHS Ester: Practical Labeling Guide

  2026-08-25

  Cy7 NHS ester is a water-soluble Sulfo-Cy7 NHS Ester protein labeling dye for attaching near-infrared fluorescence to accessible amino groups on proteins, peptides, and related biomolecules. It is useful for near-infrared fluorescent imaging and live-cell or in vivo workflows, but target-specific labeling ratios, reaction times, stability, biodistribution, and assay performance should be optimized experimentally because no directly matched paper evidence is available here.

• qPCR Quantification of Moloney Murine Leukemia Virus

  2026-08-24

  Choi, Murphy, and Nitta developed a real-time PCR assay that quantifies exogenous Moloney murine leukemia virus in mouse cells while addressing interference from endogenous retroviral sequences. The method detected viral sequences from 16 to 72 hours after infection across a three-log range and offers a faster, scalable complement to focal immunofluorescence assays.

• Mitoxantrone Workflows for ABCG2 Resistance

  2026-08-23

  Mitoxantrone is both a mechanistic DNA-damage tool and a practical probe for ABCG2-mediated multidrug resistance. This workflow translates marein-based resistance-reversal findings into controlled accumulation, viability, and apoptosis experiments while addressing DMSO handling, assay interference, and interpretation limits.

• EZ Cap™ Firefly Luciferase mRNA Workflow Guide

  2026-08-22

  Build sensitive reporter assays around Cap1-capped, polyadenylated luciferase mRNA for rapid translation, delivery, and imaging studies. This guide connects practical handling and dosing workflows with formulation-aware troubleshooting, including why citrate buffer can change functional output even when standard LNP quality metrics look acceptable.

• Carfilzomib Sensitizes ESCC to Iodine-125 Seeds

  2026-08-21

  This 2025 study shows that Carfilzomib enhances iodine-125 seed radiation in esophageal squamous cell carcinoma by intensifying endoplasmic reticulum stress and activating apoptosis, paraptosis, and ferroptosis. Its main contribution is a mechanistic framework linking proteasome-mediated proteolysis inhibition with multi-modal tumor cell death and improved radiation response.

• HD56 Prodrug PK and Humanized-Mouse IVIVC

  2026-08-21

  This 2025 study shows that the ester prodrug HD56 has more favorable permeability and pharmacokinetic behavior than its active compound, HD561, while revealing substantial species differences in ester hydrolysis. Its strongest in vivo–in vitro correlation was obtained in humanized-liver mice, supporting their use for improving the translational assessment of carboxylesterase-dependent prodrugs.

• Bay 11-7085 for Reliable Cell Assays

  2026-08-20

  A scenario-driven guide to using Bay 11-7085 (SKU B3033) as an NF-κB activation inhibitor in viability, proliferation, apoptosis, and inflammation workflows. It connects mechanism, assay controls, concentration planning, data interpretation, and practical product-selection criteria for more defensible cell-based experiments.

• GSTA1, Glutathione Depletion, and α-Amanitin Toxicity

  2026-08-20

  The reference study identifies GSTA1 as an unexpected driver of α-amanitin hepatotoxicity rather than a purely protective detoxification enzyme. By combining mouse injury models, hepatocyte experiments, multi-omics, molecular docking, DARTS, and GSTA1 silencing, the authors link NRF2-associated GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and liver-cell death.

• Bufuralol (hydrochloride) in Viability Assays

  2026-08-19

  This scenario-driven guide explains how Bufuralol (hydrochloride), SKU C5043, can be incorporated into reproducible cell viability, proliferation, and β-adrenergic modulation studies. It covers assay interpretation, organoid compatibility, solvent preparation, data comparison, and practical product-selection criteria.

• Pollen Interference in EEM Bioaerosol Classification

  2026-08-19

  The 2024 Molecules study develops a preprocessing and random-forest workflow for reducing pollen-driven interference in excitation–emission matrix fluorescence classification. Fast Fourier transform processing improved the reported classification accuracy to 89.24%, helping distinguish hazardous biological substances from spectrally similar environmental material.

• Vaccinia F1L and NLRP1 Inflammasome Evasion

  2026-08-18

  Szymanska et al. show that the vaccinia virus early protein F1L suppresses dsRNA- and ribotoxic stress-induced NLRP1 inflammasome activation in keratinocytes by limiting ZAKα-associated translation stress. The work separates this viral evasion mechanism from DPP8/9-inhibition-driven NLRP1 activation and provides a useful framework for studying stimulus-specific inflammasome regulation.

• Dual-Action Inhibitors and p38α Dephosphorylation

  2026-08-18

  The reference study shows that selected kinase inhibitors can do more than occupy the p38α active site: they can stabilize an activation-loop conformation that makes the regulatory phosphothreonine more accessible to WIP1 phosphatase. This structure-guided mechanism suggests a route to kinase inhibitors that combine catalytic blockade with accelerated target dephosphorylation, while also highlighting important limits for translating the finding to other compounds.

456 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page